Global Progesterone Market Size study & Forecast, by Type (Natural Progesterone, Synthetic Progesterone), By Mode of Delivery (Injectable, Suspended Form, Oral), By Application (Regulation of the Menstrual Cycle, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions) and Regional Analysis, 2023-2030
Global Progesterone Market is valued at approximately USD 1157.2 million in 2022 and is anticipated to grow with a healthy growth rate of more than 13.3% over the forecast period 2023-2030. Progesterone is a female hormone that is primarily produced by the ovaries after ovulation. It plays a crucial role in preparing the uterus for pregnancy and maintaining a healthy pregnancy. Progesterone also helps regulate the menstrual cycle and is involved in the development of breast tissue. It can also be used as a medication to treat various conditions, such as irregular periods, infertility, and menopausal symptoms. It is often prescribed as part of hormone replacement therapy for menopausal women. The Progesterone market is expanding because of factors such increasing incidence of endometrial cancer and growing cases of female infertility and breast cancer.
During pregnancy, progesterone levels rise significantly and help to prevent premature contractions of the uterus. After menopause, progesterone production declines, along with estrogen, which can lead to symptoms such as hot flashes, vaginal dryness, and bone loss. Its prevalence has progressively increased during the last few decades. According to the American Cancer Society, in 2023 about 66,200 new cases of cancer of the body of the uterus will be diagnosed. Furthermore, around 13,030 women will die from cancers of the uterine body in the United States. In addition, about 13,960 new cases of invasive cervical cancer will be diagnosed and 4,310 women will die from cervical cancer during the same year. Another important component driving space is increasing cases of female infertility and breast cancer. According to World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. In addition, as per the American Society of Clinical Oncology in 2023, an estimated 297,790 women in the United States will be diagnosed with invasive breast cancer, and 55,720 women will be diagnosed with non-invasive breast cancer. Also, advancements in formulation and technological advancements in the medical industry would create a lucrative growth prospectus for the market over the forecast period. However, lack of awareness regarding the availability of hormone therapy stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Progesterone Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing number of breast cancer in the region. According to Breastcancer.org, In 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive breast cancer. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising target populations, and active participation of government and nonprofit organizations in the market space.
Major market players included in this report are:
Estrellas Life Sciences Private Ltd
Bionpharma Inc.,
Sofgen Pharmaceuticals,
Teva Pharmaceuticals Industries Ltd
Virtus Pharmaceuticals Llc,
Blubell Pharma Group Company, Aquatic Remedies Pvt. Ltd.,
Intas Pharmaceuticals Ltd.,
Shanghai Yijing Industrial Co ltd
Wuhan Honor Bio-Pharm Co., Ltd
Recent Developments in the Market:
In November 2020, Prestige BioPharma Ltd. and Abic Marketing Ltd., a subsidiary of Teva Pharmaceutical Industries Ltd., signed an exclusive cooperation and supply agreement for the commercialization of Prestige BioPharma's Trastuzumab biosimilar in Israel.
Global Progesterone Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Type, Mode of Delivery, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Natural Progesterone
Synthetic Progesterone
By Mode of Delivery
Injectable
Suspended Form
Oral
By Application
Regulation of the Menstrual Cycle
Dysfunctional Uterine Bleeding
Endometrial Cancer
Contraception
Hyperplastic Precursor Lesions
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
During pregnancy, progesterone levels rise significantly and help to prevent premature contractions of the uterus. After menopause, progesterone production declines, along with estrogen, which can lead to symptoms such as hot flashes, vaginal dryness, and bone loss. Its prevalence has progressively increased during the last few decades. According to the American Cancer Society, in 2023 about 66,200 new cases of cancer of the body of the uterus will be diagnosed. Furthermore, around 13,030 women will die from cancers of the uterine body in the United States. In addition, about 13,960 new cases of invasive cervical cancer will be diagnosed and 4,310 women will die from cervical cancer during the same year. Another important component driving space is increasing cases of female infertility and breast cancer. According to World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. In addition, as per the American Society of Clinical Oncology in 2023, an estimated 297,790 women in the United States will be diagnosed with invasive breast cancer, and 55,720 women will be diagnosed with non-invasive breast cancer. Also, advancements in formulation and technological advancements in the medical industry would create a lucrative growth prospectus for the market over the forecast period. However, lack of awareness regarding the availability of hormone therapy stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Progesterone Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing number of breast cancer in the region. According to Breastcancer.org, In 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive breast cancer. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising target populations, and active participation of government and nonprofit organizations in the market space.
Major market players included in this report are:
Estrellas Life Sciences Private Ltd
Bionpharma Inc.,
Sofgen Pharmaceuticals,
Teva Pharmaceuticals Industries Ltd
Virtus Pharmaceuticals Llc,
Blubell Pharma Group Company, Aquatic Remedies Pvt. Ltd.,
Intas Pharmaceuticals Ltd.,
Shanghai Yijing Industrial Co ltd
Wuhan Honor Bio-Pharm Co., Ltd
Recent Developments in the Market:
In November 2020, Prestige BioPharma Ltd. and Abic Marketing Ltd., a subsidiary of Teva Pharmaceutical Industries Ltd., signed an exclusive cooperation and supply agreement for the commercialization of Prestige BioPharma's Trastuzumab biosimilar in Israel.
Global Progesterone Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Type, Mode of Delivery, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Natural Progesterone
Synthetic Progesterone
By Mode of Delivery
Injectable
Suspended Form
Oral
By Application
Regulation of the Menstrual Cycle
Dysfunctional Uterine Bleeding
Endometrial Cancer
Contraception
Hyperplastic Precursor Lesions
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Progesterone Market, by Region, 2020-2030 (USD Million)
1.2.2. Progesterone Market, by Type, 2020-2030 (USD Million)
1.2.3. Progesterone Market, by Mode of Delivery, 2020-2030 (USD Million)
1.2.4. Progesterone Market, by Application, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PROGESTERONE MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PROGESTERONE MARKET DYNAMICS
3.1. Progesterone Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of endometrial cancer
3.1.1.2. Growing cases of female infertility and breast cancer
3.1.2. Market Challenges
3.1.2.1. Lack of awareness regarding the availability of hormone therapy
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Technological Advancements in the Medical Industry
CHAPTER 4. GLOBAL PROGESTERONE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL PROGESTERONE MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Progesterone Market by Type, Performance - Potential Analysis
5.3. Global Progesterone Market Estimates & Forecasts by Type 2020-2030 (USD Million)
5.4. Progesterone Market, Sub Segment Analysis
5.4.1. Natural Progesterone
5.4.2. Synthetic Progesterone
CHAPTER 6. GLOBAL PROGESTERONE MARKET, BY MODE OF DELIVERY
6.1. Market Snapshot
6.2. Global Progesterone Market by Mode of Delivery, Performance - Potential Analysis
6.3. Global Progesterone Market Estimates & Forecasts by Mode of Delivery 2020-2030 (USD Million)
6.4. Progesterone Market, Sub Segment Analysis
6.4.1. Injectable
6.4.2. Suspended Form
6.4.3. Oral
CHAPTER 7. GLOBAL PROGESTERONE MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Progesterone Market by Application, Performance - Potential Analysis
7.3. Global Progesterone Market Estimates & Forecasts by Application 2020-2030 (USD Million)
7.4. Progesterone Market, Sub Segment Analysis
7.4.1. Regulation of the Menstrual Cycle
7.4.2. Dysfunctional Uterine Bleeding
7.4.3. Endometrial Cancer
7.4.4. Contraception
7.4.5. Hyperplastic Precursor Lesions
CHAPTER 8. GLOBAL PROGESTERONE MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Progesterone Market, Regional Market Snapshot
8.4. North America Progesterone Market
8.4.1. U.S. Progesterone Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Mode of Delivery breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Progesterone Market
8.5. Europe Progesterone Market Snapshot
8.5.1. U.K. Progesterone Market
8.5.2. Germany Progesterone Market
8.5.3. France Progesterone Market
8.5.4. Spain Progesterone Market
8.5.5. Italy Progesterone Market
8.5.6. Rest of Europe Progesterone Market
8.6. Asia-Pacific Progesterone Market Snapshot
8.6.1. China Progesterone Market
8.6.2. India Progesterone Market
8.6.3. Japan Progesterone Market
8.6.4. Australia Progesterone Market
8.6.5. South Korea Progesterone Market
8.6.6. Rest of Asia Pacific Progesterone Market
8.7. Latin America Progesterone Market Snapshot
8.7.1. Brazil Progesterone Market
8.7.2. Mexico Progesterone Market
8.8. Middle East & Africa Progesterone Market
8.8.1. Saudi Arabia Progesterone Market
8.8.2. South Africa Progesterone Market
8.8.3. Rest of Middle East & Africa Progesterone Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Estrellas Life Sciences Private Ltd
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bionpharma Inc.
9.3.3. Sofgen Pharmaceuticals
9.3.4. Teva Pharmaceuticals Industries Ltd
9.3.5. Virtus Pharmaceuticals Llc,
9.3.6. Blubell Pharma Group Company
9.3.7. Aquatic Remedies Pvt. Ltd.
9.3.8. Intas Pharmaceuticals Ltd.
9.3.9. Shanghai Yijing Industrial Co ltd
9.3.10. Wuhan Honor Bio-Pharm Co., Ltd
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Progesterone Market, by Region, 2020-2030 (USD Million)
1.2.2. Progesterone Market, by Type, 2020-2030 (USD Million)
1.2.3. Progesterone Market, by Mode of Delivery, 2020-2030 (USD Million)
1.2.4. Progesterone Market, by Application, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PROGESTERONE MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PROGESTERONE MARKET DYNAMICS
3.1. Progesterone Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of endometrial cancer
3.1.1.2. Growing cases of female infertility and breast cancer
3.1.2. Market Challenges
3.1.2.1. Lack of awareness regarding the availability of hormone therapy
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Technological Advancements in the Medical Industry
CHAPTER 4. GLOBAL PROGESTERONE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL PROGESTERONE MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Progesterone Market by Type, Performance - Potential Analysis
5.3. Global Progesterone Market Estimates & Forecasts by Type 2020-2030 (USD Million)
5.4. Progesterone Market, Sub Segment Analysis
5.4.1. Natural Progesterone
5.4.2. Synthetic Progesterone
CHAPTER 6. GLOBAL PROGESTERONE MARKET, BY MODE OF DELIVERY
6.1. Market Snapshot
6.2. Global Progesterone Market by Mode of Delivery, Performance - Potential Analysis
6.3. Global Progesterone Market Estimates & Forecasts by Mode of Delivery 2020-2030 (USD Million)
6.4. Progesterone Market, Sub Segment Analysis
6.4.1. Injectable
6.4.2. Suspended Form
6.4.3. Oral
CHAPTER 7. GLOBAL PROGESTERONE MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Progesterone Market by Application, Performance - Potential Analysis
7.3. Global Progesterone Market Estimates & Forecasts by Application 2020-2030 (USD Million)
7.4. Progesterone Market, Sub Segment Analysis
7.4.1. Regulation of the Menstrual Cycle
7.4.2. Dysfunctional Uterine Bleeding
7.4.3. Endometrial Cancer
7.4.4. Contraception
7.4.5. Hyperplastic Precursor Lesions
CHAPTER 8. GLOBAL PROGESTERONE MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Progesterone Market, Regional Market Snapshot
8.4. North America Progesterone Market
8.4.1. U.S. Progesterone Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Mode of Delivery breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Progesterone Market
8.5. Europe Progesterone Market Snapshot
8.5.1. U.K. Progesterone Market
8.5.2. Germany Progesterone Market
8.5.3. France Progesterone Market
8.5.4. Spain Progesterone Market
8.5.5. Italy Progesterone Market
8.5.6. Rest of Europe Progesterone Market
8.6. Asia-Pacific Progesterone Market Snapshot
8.6.1. China Progesterone Market
8.6.2. India Progesterone Market
8.6.3. Japan Progesterone Market
8.6.4. Australia Progesterone Market
8.6.5. South Korea Progesterone Market
8.6.6. Rest of Asia Pacific Progesterone Market
8.7. Latin America Progesterone Market Snapshot
8.7.1. Brazil Progesterone Market
8.7.2. Mexico Progesterone Market
8.8. Middle East & Africa Progesterone Market
8.8.1. Saudi Arabia Progesterone Market
8.8.2. South Africa Progesterone Market
8.8.3. Rest of Middle East & Africa Progesterone Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Estrellas Life Sciences Private Ltd
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bionpharma Inc.
9.3.3. Sofgen Pharmaceuticals
9.3.4. Teva Pharmaceuticals Industries Ltd
9.3.5. Virtus Pharmaceuticals Llc,
9.3.6. Blubell Pharma Group Company
9.3.7. Aquatic Remedies Pvt. Ltd.
9.3.8. Intas Pharmaceuticals Ltd.
9.3.9. Shanghai Yijing Industrial Co ltd
9.3.10. Wuhan Honor Bio-Pharm Co., Ltd
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Progesterone Market, report scope
TABLE 2. Global Progesterone Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Progesterone Market estimates & forecasts by Type 2020-2030 (USD Million)
TABLE 4. Global Progesterone Market estimates & forecasts by Mode of Delivery 2020-2030 (USD Million)
TABLE 5. Global Progesterone Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 6. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. U.S. Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. Canada Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 20. Canada Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. Canada Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. UK Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 23. UK Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. UK Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. Germany Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 26. Germany Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. Germany Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. France Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 29. France Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. France Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. Italy Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 32. Italy Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Italy Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Spain Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 35. Spain Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. Spain Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. RoE Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 38. RoE Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. RoE Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. China Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 41. China Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. China Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. India Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 44. India Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. India Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. Japan Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 47. Japan Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. Japan Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. South Korea Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 50. South Korea Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. South Korea Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. Australia Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 53. Australia Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. Australia Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. RoAPAC Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 56. RoAPAC Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. RoAPAC Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. Brazil Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 59. Brazil Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Brazil Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Mexico Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 62. Mexico Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. Mexico Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. RoLA Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 65. RoLA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. RoLA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. Saudi Arabia Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 68. South Africa Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. RoMEA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Progesterone Market
TABLE 71. List of primary sources, used in the study of global Progesterone Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Progesterone Market, report scope
TABLE 2. Global Progesterone Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Progesterone Market estimates & forecasts by Type 2020-2030 (USD Million)
TABLE 4. Global Progesterone Market estimates & forecasts by Mode of Delivery 2020-2030 (USD Million)
TABLE 5. Global Progesterone Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 6. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Progesterone Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Progesterone Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. U.S. Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. Canada Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 20. Canada Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. Canada Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. UK Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 23. UK Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. UK Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. Germany Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 26. Germany Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. Germany Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. France Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 29. France Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. France Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. Italy Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 32. Italy Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Italy Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Spain Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 35. Spain Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. Spain Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. RoE Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 38. RoE Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. RoE Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. China Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 41. China Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. China Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. India Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 44. India Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. India Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. Japan Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 47. Japan Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. Japan Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. South Korea Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 50. South Korea Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. South Korea Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. Australia Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 53. Australia Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. Australia Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. RoAPAC Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 56. RoAPAC Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. RoAPAC Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. Brazil Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 59. Brazil Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Brazil Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Mexico Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 62. Mexico Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. Mexico Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. RoLA Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 65. RoLA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. RoLA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. Saudi Arabia Progesterone Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 68. South Africa Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. RoMEA Progesterone Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Progesterone Market
TABLE 71. List of primary sources, used in the study of global Progesterone Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Progesterone Market, research methodology
FIG 2. Global Progesterone Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Progesterone Market, key trends 2022
FIG 5. Global Progesterone Market, growth prospects 2023-2030
FIG 6. Global Progesterone Market, porters 5 force model
FIG 7. Global Progesterone Market, pest analysis
FIG 8. Global Progesterone Market, value chain analysis
FIG 9. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Progesterone Market, regional snapshot 2020 & 2030
FIG 15. North America Progesterone Market 2020 & 2030 (USD Million)
FIG 16. Europe Progesterone Market 2020 & 2030 (USD Million)
FIG 17. Asia Pacific Progesterone Market 2020 & 2030 (USD Million)
FIG 18. Latin America Progesterone Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Progesterone Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Progesterone Market, research methodology
FIG 2. Global Progesterone Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Progesterone Market, key trends 2022
FIG 5. Global Progesterone Market, growth prospects 2023-2030
FIG 6. Global Progesterone Market, porters 5 force model
FIG 7. Global Progesterone Market, pest analysis
FIG 8. Global Progesterone Market, value chain analysis
FIG 9. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Progesterone Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Progesterone Market, regional snapshot 2020 & 2030
FIG 15. North America Progesterone Market 2020 & 2030 (USD Million)
FIG 16. Europe Progesterone Market 2020 & 2030 (USD Million)
FIG 17. Asia Pacific Progesterone Market 2020 & 2030 (USD Million)
FIG 18. Latin America Progesterone Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Progesterone Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
